Wolf Haldenstein Adler Freeman & Herz LLP announces the filing of a federal securities class action lawsuit against Decision Diagnostics Corp.

NEW YORK, January 22, 2021 / PRNewswire / – Wolf Haldenstein Adler Freeman & Herz LLP announces the filing of a class action lawsuit against federal securities The United States District Court for the Central District of California v Decision Diagnostics Corp. (“Decision Diagnostics” or “the Company”) (OTCBB: DECN) on behalf of investors who have between-purchased the Company’s securities March 3, 2020 and 17th December 2020, including (the ” Lesson ”)

All investors who purchase Decision Diagnostics Corp. If you have made a purchase and have suffered a loss, please contact the company immediately [email protected] or (800) 575-0735 or (212) 545-4774. For more information on the promotion, visit our website at www.whafh.com.

If you lose in the shares of Decision Diagnostics Corp. you can do so at the latest March 16, 2021, ask the court to appoint you as the lead plaintiff of the proposed class. Please contact Wolf Haldenstein Learn more about your rights as an investor in Decision Diagnostics Corp.


According to the complaint submitted, the company made false and misleading statements to the market. Decision Diagnostics couldn’t come up with a viable COVID-19 test of any kind, let alone a test that could detect the virus in less than a minute. The company was unable to meet the U.S. Food and Drug Administration’s (FDA) EUA test requirements for its alleged COVID-19 test. Despite this inability to meet FDA requirements, the company announced an unrealistic time to market for its tests. Because of these facts, the Company’s public statements were false and materially misleading throughout the class.

Wolf Haldenstein has extensive experience prosecuting class and derivative disputes in state and federal courts and appeals courts across the country. The firm has lawyers in various fields of activity and offices in new York, Chicago and San Diego. This law firm’s reputation and expertise in shareholder and other class disputes has been recognized repeatedly by the courts who have appointed them to key positions in complex securities multiple district and consolidated litigation.

If you would like to discuss this action or have questions about your rights and interests in this case, please contact us immediately Wolf Haldenstein by phone at (800) 575-0735, by email at [email protected]or visit our website at www.whafh.com.

Wolf Haldenstein Adler Freeman & Heart LLP
Kevin Cooper, Esq.
Gregory Stone, Director of Case and Financial Analysis
E-mail: [email protected], [email protected] or [email protected]
Tel .: (800) 575-0735 or (212) 545-4774

This press release may be viewed as a solicitor’s advertisement in some jurisdictions under applicable laws and ethical rules.

SOURCE Wolf Haldenstein Adler Freeman & Heart LLP

similar links


Comments are closed.